We invite you to reimagine what’s possible with cytometry.

Participate in the largest gathering of the mass cytometry community this spring and hear about the latest advances in immuno-oncology and infectious disease research.

In the 10 years since its debut, CyTOF® has moved from being a niche discovery tool to broad adoption across a wide range of research areas and use as a key component in over 130 translational and clinical research trials.

This year’s spring edition of the Fluidigm Mass Cytometry Summit will focus on investigators using the technology to gain previously unrecognized cell biology insights to develop new ways to diagnose and treat human disease.

You will also learn about fundamentals of the technology from Fluidigm experts and be among the first to hear about the latest advances in CyTOF technology.

If you use any type of cytometry in your research, take the opportunity to join this year’s Summit!

Tuesday, May 25, 2021

7:00 am–2:00 pm PT
10:00 am–5:00 pm ET
4:00–11:00 pm CET

Register now
SpeakersInformationVenue
Holden MaeckerCyTOF in the Cancer Immune Monitoring and Analysis Centers (CIMAC): Standardization and harmonization  

Holden Maecker, PhD
Professor, Microbiology and Immunology
Stanford University School of Medicine		Amphitheater         
Petter BrodinMulti-omic profiling of human immunity with CyTOF, Olink® and automated RNA-seq  

Petter Brodin, MD, PhD
Associate Professor of Immunology
Director, Science for Life Laboratory
Mass Cytometry Facility
Karolinska Institutet		Amphitheater
Erika J. CrosbyLong-term tracking of vaccine-elicited tumor antigen-specific T cell responses in cancer patients using CyTOF

Erika J. Crosby, PhD
Department of Surgery
Office of Biomedical Graduate Education
RCR/R&R Curriculum Manager
Duke University Medical Center		Amphitheater
Yann AbrahamFound in translation: Data-Driven analysis of single-cell proteomics data in clinical trials

Yann Abraham, PhD
Principal Scientist
Discovery Sciences, Janssen Pharmaceutical Companies of Johnson & Johnson		Amphitheater
Deborah CrossUnderstanding vaccine-mediated protection against typhoid fever: Insights from human challenge models

Deborah Cross, MRes BSc
Oxford Vaccine Group, Department of Paediatrics
NIHR Oxford Biomedical Research Centre
University of Oxford		Amphitheater
Michael FehlingsSARS-CoV-2 specific CD8+ T cell responses in convalescent COVID-19 individuals

Michael Fehlings, PhD
Vice President of Operations and Development
ImmunoScape		Amphitheater

Register today for the Fluidigm Mass Cytometry Summit, Spring 2021.

Please create a unique Username and Password for entrance to the Summit in the form below.
* You may withdraw your consent anytime in every email you will receive from us. To learn more about how we use your information, read our Privacy Policy.